Pancreatic cancer: role of the immune system in cancer progression and vaccine-based immunotherapy - Wikidata - wikimedia - TriplyDB

Pancreatic cancer: role of the immune system in cancer progression and vaccine-based immunotherapy

Pancreatic cancer: role of the immune system in cancer progression and vaccine-based immunotherapy

http://www.wikidata.org/entity/Q35886496

about

Harnessing the immune system to improve cancer therapy Various diffusion magnetic resonance imaging techniques for pancreatic cancer Management of pancreatic cancer in the elderly Pancreatic cancer: yesterday, today and tomorrow.Chemical compounds from anthropogenic environment and immune evasion mechanisms: potential interactions Rare long-term survivors of pancreatic adenocarcinoma without curative resection.Role of immune cells in pancreatic cancer from bench to clinical application: An updated review Prognostic value of PDL1 expression in pancreatic cancer Immunodeficiency in Pancreatic Adenocarcinoma with Diabetes Revealed by Comparative Genomics.Immunotherapy for pancreatic cancer.Differentiated State of Initiating Tumor Cells Is Key to Distinctive Immune Responses Seen in H-RasG12V-Induced Squamous Tumors.Interleukin-15 stimulates natural killer cell-mediated killing of both human pancreatic cancer and stellate cells.Cholecystokinin receptor antagonist alters pancreatic cancer microenvironment and increases efficacy of immune checkpoint antibody therapy in mice.Efficacy of vaccination with tumor-exosome loaded dendritic cells combined with cytotoxic drug treatment in pancreatic cancer.Human Pancreatic Cancer Cells Induce a MyD88-Dependent Stromal Response to Promote a Tumor-Tolerant Immune Microenvironment.

P2860

Q26738698-AD1014E3-B152-41CA-AE23-7BDF089FE1AC Q26769804-6083A787-AB44-41B7-A4A7-E0C242A3D779 Q26774639-7D95D0A4-AB7D-4EA8-936D-AA6B529E3AA2 Q30250026-B7446077-9199-4038-9B0D-E74B600E4EDA Q34477550-266DBDDB-56FA-4E9D-9D23-9F06D625E693 Q36401628-EEBF6F8C-65A8-48A2-8336-E42F6E831CC9 Q37606102-95022DB4-2C7B-4864-8E41-5BE579D812E1 Q37687595-27173AF7-79C4-4C36-85D9-961CF93C6FB0 Q38690307-3760270A-4942-4027-A13D-D2BD307BDCD4 Q38722325-D8B35B12-4CE9-4329-9146-85EA27AB6EDF Q38991275-B6D77FC5-4701-4EB5-B760-ACAD808AA97E Q41343761-46EABA9D-9DA4-47FE-ADAF-EA26125A7925 Q50085980-9E9ADC5C-4349-476D-9227-B647770573EA Q50544084-F252927A-4EED-4BF3-8AFD-FEEA55236BB9 Q50610770-620F5221-B08A-4095-8814-C736AD455075

P2860

Pancreatic cancer: role of the immune system in cancer progression and vaccine-based immunotherapy

http://www.wikidata.org/entity/Q35886496

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Pancreatic cancer: role of the ...... nd vaccine-based immunotherapy

@ast

Pancreatic cancer: role of the ...... nd vaccine-based immunotherapy

@en

type

label

Pancreatic cancer: role of the ...... nd vaccine-based immunotherapy

@ast

Pancreatic cancer: role of the ...... nd vaccine-based immunotherapy

@en

prefLabel

Pancreatic cancer: role of the ...... nd vaccine-based immunotherapy

@ast

Pancreatic cancer: role of the ...... nd vaccine-based immunotherapy

@en

P1433

Q35886496-9EC86E2D-4905-405F-AF5F-11C07984C0F0

P1476

Q35886496-81015BAB-D9D2-49CE-B2F3-9DFC54A9AAC9

P2093

Q35886496-1E4A8D23-275B-4C2F-888B-9D0548864400

P2860

Q35886496-003E20FD-994A-417B-9682-08A2D2CDF034

Q35886496-01C37492-3DB6-424E-A799-8509871379F4

Q35886496-022796B0-1C79-4817-A70F-F38FE4BF932C

Q35886496-029C7C76-FAA8-4E4F-8A2B-5DB64A3B6A28

Q35886496-047A9E03-03B3-463F-90B1-8E90B747EA9B

Q35886496-05495A32-AEB9-4592-842E-C114F646A044

Q35886496-07912718-7753-46CB-AB18-A2EF02FE3EAD

Q35886496-0907C255-6FA0-47EB-8D2F-E0F831D0D1E9

Q35886496-0D910F2D-F534-44BB-A81B-E3D81C155174

Q35886496-0F73E520-1E37-483D-8F31-FE08CF78525F

P304

Q35886496-9DF94C30-0EDD-41B5-AC84-3B6ECEE7F620

P31

Q35886496-FCF2EAF4-94C5-4632-9C7A-73B708B05F4A

P356

Q35886496-0978259C-04B6-43CA-BB8B-31F105B28843

P433

Q35886496-64DF978E-8BCB-4889-B3D3-B85984A3DC4F

P478

Q35886496-5F0A83AE-7AAF-49F5-A80C-0EEEB9CF1302

P50

Q35886496-5C2484E3-49E6-4548-98BD-6779A69B42FC

Q35886496-C7B7FD65-E163-43E9-9056-1F14094E2116

P577

Q35886496-2785376E-AF6A-4166-9872-7F8042BC8EA1

P698

Q35886496-ACD865AF-F728-48BF-942B-2B76F3B4F70E

P932

Q35886496-09A8F7ED-EA1F-4139-B38D-B701E1340E77

P356

P1433

Human Vaccines & Immunotherapeutics

P1476

Pancreatic cancer: role of the ...... nd vaccine-based immunotherapy

@en

P2093

Elena Niccolai

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

Circulating mesothelin protein and cellular antimesothelin immunity in patients with pancreatic cancer

Telomerase peptide vaccination of patients with non-resectable pancreatic cancer: A dose escalating phase I/II study

Pathways for aberrant angiogenesis in pancreatic cancer

Randomized phase II--study evaluating EGFR targeting therapy with cetuximab in combination with radiotherapy and chemotherapy for patients with locally advanced pancreatic cancer--PARC: study protocol [ISRCTN56652283].

Mechanisms driving macrophage diversity and specialization in distinct tumor microenvironments and parallelisms with other tissues

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

Novel allogeneic granulocyte-macrophage colony-stimulating factor-secreting tumor vaccine for pancreatic cancer: a phase I trial of safety and immune activation

P304

3354-3368

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/HV.34392

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

Domenico Prisco

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25483688

http://www.w3.org/2001/XMLSchema#string

P932

4514060

http://www.w3.org/2001/XMLSchema#string